Confluence's $100 million acquisition is a win for St. Louis' biotech sector

GUEST: Yesterday, BioGenerator's first co-working lab tenant, Confluence Life Sciences, got acquired by Aclaris Therapeutics, Inc. at a valuation of $100 million. On the acquisition, Confluence’s lead founder Joe Monahan said in a press release, “We are thrilled to achieve this significant milestone. … We built a team of proven drug hunters, successfully advanced multiple product candidates to […]